AI Summary
This grant opportunity, PAR-26-025 (CFDA: 93.286), is for the Bioengineering Research, Innovation and Technology Education (BRITE) Program. It does not allow clinical trials. The purpose is to fund bioengineering research, innovation, and technology education programs.